Press-release for stocks related to events for cstl

Prices are updated after-hours

tags : Events symbols : Cstl

save search

Castle Biosciences to Release Fourth Quarter and Full-Year 2023 Financial Results and Host Conference Call on Wednesday, Feb. 28, 2024
Published: 2024-02-07 (Crawled : 13:00) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology

| -21.05% | O: 0.79% H: 1.29% C: -2.98%
conference financial results

Castle Biosciences to Release Third Quarter 2023 Financial Results and Host Conference Call on Thursday, Nov. 2
Published: 2023-10-19 (Crawled : 12:30) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology

| 45.47% | O: -0.46% H: 0.23% C: -1.23%
conference financial results

Castle Biosciences Presents New Data at ASTRO 2023 Highlighting Risk-Stratification Performance of DecisionDx®-SCC in Patients with Cutaneous Squamous Cell Carcinoma Eligible for Adjuvant Radiation Therapy
Published: 2023-10-03 (Crawled : 13:00) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology

| 15.28% | O: -0.97% H: 0.0% C: -3.81%
decisiondx cell therapy

Castle Biosciences, Leading Skin Cancer Expert, Darrell Rigel, M.D., M.S., and IMPACT Melanoma Board Member to Ring Nasdaq Closing Bell on Sept. 27, 2023, to Raise Awareness of Melanoma
Published: 2023-09-25 (Crawled : 12:00) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology

| 14.65% | O: 0.85% H: 0.0% C: -0.84%
melanoma nasdaq bell cancer impact skin

Castle Biosciences to Host Second Annual Castle Cares Charity Walk
Published: 2023-07-18 (Crawled : 14:20) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology

| 14.79% | O: 0.61% H: 4.58% C: 1.39%
cares

Castle Biosciences to Present New DecisionDx®-SCC and DecisionDx®-Melanoma Data at the American Head & Neck Society’s (AHNS) 11th International Conference on Head and Neck Cancer
Published: 2023-07-07 (Crawled : 15:00) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology

| 42.62% | O: 50.6% H: 4.8% C: 1.5%
decisiondx conference cancer international

Castle Biosciences Celebrates Skin Cancer Awareness Month
Published: 2023-05-30 (Crawled : 12:20) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology

| -27.15% | O: 0.04% H: 2.65% C: -5.34%
cancer skin

Castle Biosciences Collaborates with IMPACT Melanoma to Provide Free Sunscreen to Cyclists Participating in the Bike MS: Texas MS 150 2023 Cycling Event
Published: 2023-04-28 (Crawled : 13:20) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology

| -14.49% | O: -0.41% H: 3.67% C: 2.58%
150 melanoma free impact

Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
Published: 2023-03-14 (Crawled : 12:20) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology

| -5.25% | O: 4.2% H: 4.46% C: 4.13%
sciences life

Castle Biosciences to Highlight Clinical Value of Its Skin Cancer Tests at the 2023 American Academy of Dermatology (AAD) Annual Meeting
Published: 2023-03-10 (Crawled : 14:00) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology

| -11.0% | O: -0.14% H: 3.72% C: -8.38%
meeting skin cancer

Castle Biosciences to Release Third Quarter 2022 Financial Results and Host Conference Call on Wednesday, Nov. 2
Published: 2022-10-19 (Crawled : 12:00) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology

| -19.44% | O: -1.66% H: 2.68% C: -5.23%
conference financial results

Castle Biosciences Presents Case Study Showcasing the Diagnostic Performance of DiffDx®-Melanoma at the College of American Pathologists 2022 (CAP22) Annual Meeting
Published: 2022-10-11 (Crawled : 12:00) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology

| -21.38% | O: -0.21% H: 1.79% C: 0.25%
cap22 diffdx meeting diagnostic study

Castle Biosciences to Host Investor Day on Sept. 20, 2022
Published: 2022-08-24 (Crawled : 12:00) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology

| -38.88% | O: -0.13% H: 4.72% C: 3.68%
day

Castle Biosciences to Present at the Canaccord Genuity 42nd Annual Growth Conference
Published: 2022-08-03 (Crawled : 12:00) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology

| -35.11% | O: 1.4% H: 1.45% C: 0.44%
conference growth

Castle Biosciences Collaborates with The Sun Bus to Provide Free Skin Cancer Screenings
Published: 2022-05-10 (Crawled : 12:00) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology

| -7.38% | O: -5.33% H: 7.7% C: 4.75%
skin cancer collaboration

Castle Biosciences Presents Data on Its Inflammatory Skin Disease Pipeline Test at the 4th Annual Revolutionizing Atopic Dermatitis (RAD) Conference
Published: 2022-04-18 (Crawled : 12:00) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology

| -34.49% | O: -10.41% H: 0.0% C: -5.98%
conference disease test dermatitis skin

Castle Biosciences Receives Advanced Diagnostic Laboratory Test (ADLT) Status for TissueCypher® Barrett’s Esophagus Test from the Centers for Medicare & Medicaid Services (CMS)
Published: 2022-03-29 (Crawled : 22:00) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology

| -55.39% | O: 2.03% H: 6.86% C: 5.77%
tissuecypher diagnostic services test

Castle Biosciences to Release Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call on Monday, Feb. 28, 2022
Published: 2022-02-14 (Crawled : 12:30) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology

| -56.42% | O: -0.4% H: 4.29% C: 0.94%
day financial results ces conference bioscience results

Castle Biosciences to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Published: 2022-02-07 (Crawled : 13:00) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology

| -55.36% | O: 1.0% H: 6.93% C: 2.94%
health ces thc conference bioscience svb leerink global

Castle Biosciences to Present at the 24th Annual Needham Growth Conference
Published: 2021-12-28 (Crawled : 13:00) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K

Health Technology